Overview

Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)

Status:
Completed
Trial end date:
2019-05-28
Target enrollment:
Participant gender:
Summary
This study evaluates the use of Brimonidine tartrate nanoemulsion eye drop solution in the treatment of Dry Eye Disease (DED). Half of participants will receive Brimonidine and half will receive ophthalmic buffered saline (placebo).
Phase:
Phase 3
Details
Lead Sponsor:
Ocugen
Treatments:
Brimonidine Tartrate
Ophthalmic Solutions